CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Bioiasis AD is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Bioiasis AD
70, Ralevitsa Str., Atelier 1
Phone: +359 24807788p:+359 24807788 SOFIA, 1618  Bulgaria Ticker: BIOABIOA
Business Summary
Bioiasis AD is a Bulgaria-based company that specializes in the wholesale of biomaterial products surgical supplies such as medicines, medical materials and instruments, sanitary and hygienic products, disinfectants, medical cosmetics and appliances, as well as medical equipment and consumables. The Company distributes cardiology products like Paclitaxel Eluting Balloon and Paclitaxel Eluting Stent; orthopedics products like Lineage Acetabular Cups, Advance Medical Pivot Knee and Olympia Total Shoulder System; neurosurgery products like pressure valve, mano-pressure valve, cervical disc, cervical cage and anterior cervical plate; and hemostasis products like haemostatic gauze, haemostatic powder and resorbable collagen hemostat. The Company distributes its products nationally and internationally, in Bulgaria, Greece, Cyprus, Romania, Serbia, the Russian Federation and the United States.

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
YesYes-----

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
9/30/202412/31/2023Yes----

Industries
SIC Code Description
5047 Medical, dental, and hospital equipment and supplies
5048 Ophthalmic goods

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Chief Executive Officer, Director GerganaYordanova 6/8/2015 5/28/2015
Director DimitriosDumbalis 9/5/2013 9/5/2013
Director ParaskeviKisas 9/5/2013 9/5/2013

Business Names
Business Name
4OE
BIOA
Bioiasis AD Sofia

General Information
Outstanding Shares: 1,171,215 (As of 9/30/2024)
Stock Exchange: BUL
Fax Number: +359 29207667


Copyright © 2024 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Wednesday, November 20, 2024